These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1059704)
21. Potentiation of the immune response to influenza virus subunit vaccines. Webster RG; Glezen WP; Kasel JA; Laver WG Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104 [TBL] [Abstract][Full Text] [Related]
22. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909 [TBL] [Abstract][Full Text] [Related]
23. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725 [TBL] [Abstract][Full Text] [Related]
24. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989 [TBL] [Abstract][Full Text] [Related]
25. [Antigenic characterization of hemagglutinin and neuraminidase in strains of influenza B virus isolated in Italy in the years 1962, 1967 and 1971]. Profeta ML; Zanetti AR; Bergamini F Boll Ist Sieroter Milan; 1974; 53(2):342-50. PubMed ID: 4425573 [No Abstract] [Full Text] [Related]
26. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type. Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350 [TBL] [Abstract][Full Text] [Related]
27. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795 [TBL] [Abstract][Full Text] [Related]
28. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza. Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537 [No Abstract] [Full Text] [Related]
29. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
30. Antigens (and recombinants) and immune response to avian influenza. Easterday BC Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217 [No Abstract] [Full Text] [Related]
31. Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles. Kreuter J; Liehl E J Pharm Sci; 1981 Apr; 70(4):367-71. PubMed ID: 7229943 [TBL] [Abstract][Full Text] [Related]
32. Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens. Smith AJ; Davies JR J Hyg (Lond); 1976 Oct; 77(2):271-82. PubMed ID: 185291 [TBL] [Abstract][Full Text] [Related]
33. The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines. Crawford CR; Jennings R; Bradford N; Potter CW Clin Exp Immunol; 1982 Jun; 48(3):739-46. PubMed ID: 6811173 [TBL] [Abstract][Full Text] [Related]
34. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. Couch RB Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573 [TBL] [Abstract][Full Text] [Related]
35. Clinical trials with a new influenza subunit vaccine in adults and children. Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311 [TBL] [Abstract][Full Text] [Related]
36. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author's transl)]. Werner J; Kuwert EK; Stegmaier R; Simböck H Zentralbl Bakteriol A; 1980 Feb; 246(1):1-9. PubMed ID: 7424233 [TBL] [Abstract][Full Text] [Related]
37. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study. Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837 [TBL] [Abstract][Full Text] [Related]